GRACE :: Global Resource for Advancing Cancer Education
Share
  • Recent GRACE News & Posts

    • Denise Brock Lung Cancer Video Library - Spanish Language: Video #36 Treatment Options for Acquired Resistance to EGFR TKIs: T790M-Negative Disease [GRACE :: Lung Cancer]
      Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International University discusses treatment options for acquired resistance to EGFR TKIs: T790M-negative disease.
    • Denise Brock Lung Cancer Video Library - Spanish Language: Video #35 Treatment Options for Acquired Resistance to EGFR TKIs: T790M-Positive Disease [GRACE :: Lung Cancer]
      Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International University discusses treatment options for acquired resistance to EGFR TKIs: T790M-positive disease.
    • Denise Brock Lung Cancer Video Library - Spanish Language: Video #34 Acquired Resistance to Targeted Therapies: Biology and Different Clinical Patterns [GRACE :: Lung Cancer]
      Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International University discusses acquired resistance to targeted therapies: biology, different clinical patterns.
    • Denise Brock Lung Cancer Video Library - Spanish Language: Video #33 Current Standards and Leading Options for First-line Treatment of EGFR Mutation-Positive NSCLC [GRACE :: Lung Cancer]
      Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International University discusses current standards and options for first-line treatment of EGFR mutation-positive NSCLC.
    • Denise Brock Lung Cancer Video Library - Spanish Language: Video #32 Different Types of EGFR Mutations and their Potential Clinical Implications [GRACE :: Lung Cancer]
      Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International University joined GRACE to discuss different types of EGFR mutations and their potential clinical implications.
    • Denise Brock Lung Cancer Video Library - Spanish Language: Video #31 EGFR Mutation: What Is It, and Which Patients Have It? [GRACE :: Lung Cancer]
      Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International University joined GRACE to discuss EGFR mutation: what is it, and which patients have it?
    • Denise Brock Lung Cancer Video Library - Spanish Language: Video #30 Time to Response on Immune Checkpoint Inhibitors and the Concept of Pseudoprogression [GRACE :: Lung Cancer]
      Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, & Clinical Associate Prof. of Medicine at FL International University joined GRACE to discuss the response time on checkpoint inhibitors and the concept of pseudoprogression.
    • Denise Brock Lung Cancer Video Library - Spanish Language: Video #29 Similarities and Differences Among Immune Checkpoint Inhibitors [GRACE :: Lung Cancer]
      Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International U. joined GRACE to discuss similarities and differences among immune checkpoint inhibitors.
    • Denise Brock Lung Cancer Video Library - Spanish Language: Video #28 Biomarkers for Predicting Activity of Immune Checkpoint Inhibitors [GRACE :: Lung Cancer]
      Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International U. joined GRACE to discuss biomarkers for predicting activity of immune checkpoint inhibitors.
    • Denise Brock Lung Cancer Video Library - Spanish Language: Video #27 Potential Side Effects of Immune Checkpoint Inhibitors and Basic Management Approaches [GRACE :: Lung Cancer]
      Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International U. joined GRACE to discuss potential side effects of immune checkpoint inhibitors and basic management approaches.
    • Denise Brock Lung Cancer Video Library - Spanish Language: Video #26 Integrating Immune Checkpoint Inhibitors Into First-Line Therapy for Advanced NSCLC [GRACE :: Lung Cancer]
      Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International U. joined GRACE to discuss integrating immune checkpoint inhibitors into first-line therapy for advanced NSCLC.
    • Denise Brock Lung Cancer Video Library - Spanish Language: Video #25 Second-line Therapies for Advanced NSCLC [GRACE :: Lung Cancer]
      Dr. Luis Raez, MD FACP FCCP, Chief of Hematology/Oncology and Medical Director at Memorial Cancer Institute, and Clinical Associate Professor of Medicine at Florida International University joined GRACE to discuss second-line therapies for advanced NSCLC.

Ask Us, Q&A

Join the GRACE Faculty

Lung/Thoracic Cancer Blog
Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog

Subscribe to the GRACEcast Podcast on iTunes

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Recent GRACE Forum Replies

Other Resources

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243